Hodgkin Lymphoma | A Comprehensive Overview
Idioma: inglés
Editorial: Springer, 2021
- Tapa blanda
- Nuevo

Librería: preigu, Osnabrück, Alemaniapreigu
Vendedor de AbeBooks desde 5 de agosto de 2024
Condición: Nuevo
EUR 113,20
Cantidad disponible: 5 disponibles
Añadir al carritoDescripción del artículo del vendedor
N° de ref. del artículo 119740653
- Título
- Hodgkin Lymphoma | A Comprehensive Overview
- Autor
- Andreas Engert (u. a.)
- Editorial
- Springer
- Año de publicación
- 2021
- Estado
- Neu
- Encuadernación
- Taschenbuch
- Idioma
- inglés
- ISBN 10
- 3030324842
- ISBN 13
- 9783030324841
- Edición
- 3ª Edición
- Peso del artículo
- 1101 gramos
- Dimensiones
- 254 x 178 x 27 mm
- Serie
- Libro 10 de 15: Hematologic Malignancies
- Catálogos de vendedores
- Bücher
This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progressin the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Andreas Engert, MD, is a professor of internal medicine, hematology and oncology. He received his medical degree at the Hannover Medical School and the University of Cologne (Germany). Between 1988 and 1990, he worked at the Imperial Cancer Research Fund and the Royal Free Hospital in London on new immunotherapeutic approaches. Since then, his group focused on developing antibody-based immunotherapy for patients with malignant lymphoma leading to a number of phase I/II clinical trials. He finished his postdoctoral lecture qualification in 1995, was appointed consultant at the University Hospital of Cologne and became head of staff 1996. He was elected editor of the Cochrane Hematological Malignancies Group between 2000 and 2012 and vice director of the Department for Hematology and Oncology since 2000.
After serving as secretary of the German Hodgkin Study Group (GHSG) since 1999, he was elected GHSG chairman in 2007. In May 2012, the University of Belgrade awarded him an honorary doctorate and he became EHA Executive Board member of Directors between 2012 and 2018. He was appointed Editor-in-Chief of HemaSphere, the new EHA journal in 2018. Professor Engert has published more than 400 original papers in journals such as NEJM, Lancet and others (impact factor, 2007-2017: 1928,4 points).
He received a number of awards including the Ludwig-Heilmeyer-Medal, the DGHO Arthur-Pappenheim Prize, the Research Award of the University of Cologne, the award of the German Cancer Society 2011, the Paul-Martini-Prize 2013 and the John Ultmann Lymphoma Award 2017 and others.
Dr. Anas Younes is a member of Memorial Sloan Kettering Cancer Center (MSKCC) Lymphoma Service, and professor of medicine at Weill-Cornell Medical College in New York. He is an international expert in both Hodgkin’s and non-Hodgkin’s lymphoma. Between 2013-2016 he served as chief of the lymphoma service at MSKCC; prior to that he was director of clinical and translational research at the Department of Lymphoma and Myeloma at MD Anderson Cancer Center. During his leadership tenure at MDACC and MSKCC, 10 drugs were approved by the FDA for the treatment of Hodgkin and non-Hodgkin lymphoma. He currently serves as the cancer center’s special advisor to the chief of medicine for research, and holds the Steven Greenberg Chair.
Dr Younes also conducts laboratory-based research aiming at translating the current knowledge into innovative clinical trials to improve the cure rate and survival of patients with Hodgkin and non-Hodgkin lymphoma. He led the trials that resulted in the FDA approval of brentuximab vedotin and nivolumab for the treatment of patients with relapsed Hodgkin lymphoma.
Dr. Younes has published more than 250 papers, and served as the principal investigator of more than 60 clinical trials and has led the National Cancer Institute-funded SPORE (Specialized Programs of ResearchExcellence). He is also the principal investigator of a SCOR grant supported by the Leukaemia and Lymphoma Society focusing on the development of CAR T cell therapy for lymphoma.
“Acerca de” puede pertenecer a otra edición de este título.
preigu
Osnabrück, Alemania
Vendedor de AbeBooks desde 5 de agosto de 2024
Tarifas de envío de Alemania a Estados Unidos de America
| Artículo | De 60 a 60 días hábiles | De 60 a 60 días hábiles |
|---|---|---|
| Primer artículo | EUR 70,00 | EUR 70,00 |
Métodos de pago
- PayPal
Descripción de la tienda
Especialidad
Bücher, SpielwarenInformación empresarial del vendedor
preigu GmbH & Co. KG
Lengericher Landstraße 19
Osnabrück, Alemania 49078
Condiciones de venta
About Us
Legal website operator identification:
preigu GmbH & Co. KG
Lengericher Landstr. 19
49078 Osnabrück
Germany
Telephone: +49 (0) 541 / 580 72 84
Email: mail@preigu.de
VAT No: DE 455 380 498
AG Osnabrück - HRA 209647
PhG: preigu Verwaltung GmbH
AG Osnabrück - HRB 221793
CEO: Ansas Meyer
We are neither willing nor obliged to participate in dispute resolution proceedings before consumer arbitration boards.
We are a member of the initiative "FairCommerce" since 30.11.2016.
For more information, see: https://www.haendlerbund.de/de/haendlerbund/interessenvertretung/faircommerce
Derecho al desistimiento
Instructions for revocation
Right of withdrawal for the sale of goods
Revocation right for consumers
(A ‘consumer' is any natural person who concludes a legal transaction which, to an overwhelming extent, cannot be attributed to either his commercial or independent professional activities.)
Instructions for revocation
Revocation right
You have the right to revoke this contract within 14 days without specifying any reasons.
The revocation period is 14 days with effect from the day,
-
on which you or a third party nominated by you, which is not the carrier, had taken possession of the products, provided you had ordered one or more products within the scope of a standard order and this/these product/products is/are delivered uniformly;
-
on which you or a third party nominated by you, which is not the carrier, had taken possession of the last product, provided you had ordered several products within the scope of a standard order and these products are delivered separately;
-
on which you or a third party nominated by you, which is not the carrier, had taken possession of the last part delivery or the last unit, provided you had ordered a product, which is delivered in several part deliveries or units;
To exercise your right of withdrawal, you must inform us (preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, Telephone number: +49 (0) 541 / 580 72 84, E-Mail address: mail@preigu.de) by means of a clear declaration (e.g. a letter sent by post, or an e-mail) of your decision to withdraw from this contract. You can use the attached model withdrawal form for this purpose, which is, however, not mandatory.
You can also exercise your right of withdrawal online by clicking on a button labelled accordingly (such as ‘Withdraw from contract' or similar) on the AbeBooks/ZVAB website. If you use this online function, you will immediately receive a confirmation of receipt on a durable medium (e.g. via email) containing information on the content of the withdrawal notice, as well as the date and time of its receipt.
In order to safeguard the revocation period, it is sufficient that you send the notification about the exercise of the revocation right before the expiry of the revocation period.
Consequences of the revocation
If you revoke this contract, we shall repay all the payments, which we received from you, including the delivery costs (with the exception of additional costs, which arise from that fact that you selected a form of delivery other than the most reasonable standard delivery offered by us), immediately and at the latest within 14 days from the day on which we received the notification about the revocation of this contract from you. We use the same means of payment, which you had originally used during the original transaction, for this repayment unless expressly agreed otherwise with you; you will not be charged any fees owing to this repayment.
We can refuse the repayment until the products are returned to us or until you have furnished evidence that you have sent the products back to us, depending on whichever is earlier.
You must return or transfer the products to us immediately and, in any case, at the latest within 14 days with effect from the day on which you inform us of the revocation of this contract. The deadline is maintained if you send the products before the expiry of the 14 day deadline.
You bear the direct costs for returning the products.
You must pay for any depreciation of the products only if this depreciation can be attributed to any handling with you that was not necessary for checking the condition, features and functionality of the products.
Criteria for exclusion or expiry
The revocation right is not available for contracts
-
for delivery of products, which are not prefabricated and for whose manufacturing an individual selection or stipulation by the consumer is important or which are clearly tailored to the personal requirements of the consumer;
-
for delivery of products, which can spoil quickly or whose use-by date would be exceeded quickly;
-
for delivery of alcoholic drinks, whose price was agreed at the time of concluding the contract, which however can be delivered 30 days after the conclusion of the contract at the earliest and whose current value depends on the fluctuations in the market, on which the entrepreneur has no influence;
-
for delivery of newspapers, periodicals or magazines with the exception of subscription contracts. The revocation right expires prematurely in case of contracts
-
for delivery of sealed products, which are not suitable for return for reasons of health protection or hygiene if their seal has been removed after the delivery;
-
for delivery of products if they have been mixed inseparably with other goods after the delivery, owing to their condition;
-
for delivery of sound or video recording or computer software in a sealed package if the seal has been removed after the delivery.
Specimen - revocation form
(If you wish to revoke the contract, please fill up this form and send it back to us.)
-
To preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, Email address: mail@preigu.de :
-
I/we () herewith revoke the contract concluded by me/ us () regarding the purchase of the following products ()/
the provision of the following service () -
Ordered on ()/ received on ()
-
Name of the consumer(s)
-
Address of the consumer(s)
-
Signature of the consumer(s) (only in case of a notification on paper)
-
Date
(*) Cross out the incorrect option.